Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 752 entries
Sorted by: Best Match Show Resources per page
Sociodemographic differences in young adults' recall of tobacco and cannabis marketing online and in television/film

Latinx/Hispanic ethnicity

Krueger EA, Bello MS, Unger J.
GSID: lcWHBuPB6rUJ
EA Krueger, MS Bello, J Unger, TB Cruz… - Preventive medicine …, 2021 - Elsevier

… characteristics, such as race/ethnicity, gender identity, sexual identity, and socioeconomic status in YA. … The largest percentage of both samples were Latinx/Hispanic (45.0% and 44.2%, …

Cite
Krueger, E. A., Bello, M. S., Unger, J., Cruz, T. B., Barrington-Trimis, J. L., Braymiller, J. L., ... & Leventhal, A. M. (2021). Sociodemographic differences in young adults’ recall of tobacco and cannabis marketing online and in television/film. Preventive medicine reports, 24, 101592.
Krueger, Evan A., et al. "Sociodemographic differences in young adults’ recall of tobacco and cannabis marketing online and in television/film." Preventive medicine reports 24 (2021): 101592.
Copy Download .nbib Format: MLA
Principal Innovator: The Other PI.

Academic medicine : journal of the Association of American Medical Colleges

Ungar T, Marcus M.
PMID: 27676621
Acad Med. 2016 Oct;91(10):1330. doi: 10.1097/ACM.0000000000001340.

No abstract available.

Cite
Ungar T, Marcus M. Principal Innovator: The Other PI. Acad Med. 2016;91(10):1330doi: 10.1097/ACM.0000000000001340.
Ungar, T., & Marcus, M. (2016). Principal Innovator: The Other PI. Academic medicine : journal of the Association of American Medical Colleges, 91(10), 1330. https://doi.org/10.1097/ACM.0000000000001340
Ungar, Thomas, and Marcus, Madalyn. "Principal Innovator: The Other PI." Academic medicine : journal of the Association of American Medical Colleges vol. 91,10 (2016): 1330. doi: https://doi.org/10.1097/ACM.0000000000001340
Ungar T, Marcus M. Principal Innovator: The Other PI. Acad Med. 2016 Oct;91(10):1330. doi: 10.1097/ACM.0000000000001340. PMID: 27676621.
Copy Download .nbib Format: NLM
Differences Among Angiotensin II Type 1 Receptor Blockers: Characteristics of Candesartan Cilexetil.

Blood pressure

Unger T.
PMID: 28425794
Blood Press. 2000;9:14-18. doi: 10.1080/080370500439164.

Several angiotensin II type 1 (AT 1 ) receptor blockers are now available for the treatment of hypertension. Although the agents in this class all act by blocking the AT 1 -receptor, they differ in their pharmacokinetics and binding...

Cite
Unger T. Differences Among Angiotensin II Type 1 Receptor Blockers: Characteristics of Candesartan Cilexetil. Blood Press. 2000;9:14-18doi: 10.1080/080370500439164.
Unger, T. (2000). Differences Among Angiotensin II Type 1 Receptor Blockers: Characteristics of Candesartan Cilexetil. Blood pressure, 914-18. https://doi.org/10.1080/080370500439164
Unger, Thomas. "Differences Among Angiotensin II Type 1 Receptor Blockers: Characteristics of Candesartan Cilexetil." Blood pressure vol. 9 (2000): 14-18. doi: https://doi.org/10.1080/080370500439164
Unger T. Differences Among Angiotensin II Type 1 Receptor Blockers: Characteristics of Candesartan Cilexetil. Blood Press. 2000;9:14-18. doi: 10.1080/080370500439164. PMID: 28425794.
Copy Download .nbib Format: NLM
Metabolomic biomarkers of pancreatic cancer: a meta-analysis study.

Oncotarget

Mehta KY, Wu HJ, Menon SS, Fallah Y, Zhong X, Rizk N, Unger K, Mapstone M, Fiandaca MS, Federoff HJ, Cheema AK.
PMID: 28978166
Oncotarget. 2017 Aug 18;8(40):68899-68915. doi: 10.18632/oncotarget.20324. eCollection 2017 Sep 15.

Pancreatic cancer (PC) is an aggressive disease with high mortality rates, however, there is no blood test for early detection and diagnosis of this disease. Several research groups have reported on metabolomics based clinical investigations to identify biomarkers of...

Cite
Mehta KY, Wu HJ, Menon SS, et al. Metabolomic biomarkers of pancreatic cancer: a meta-analysis study. Oncotarget. 2017;8(40):68899-68915doi: 10.18632/oncotarget.20324.
Mehta, K. Y., Wu, H. J., Menon, S. S., Fallah, Y., Zhong, X., Rizk, N., Unger, K., Mapstone, M., Fiandaca, M. S., Federoff, H. J., & Cheema, A. K. (2017). Metabolomic biomarkers of pancreatic cancer: a meta-analysis study. Oncotarget, 8(40), 68899-68915. https://doi.org/10.18632/oncotarget.20324
Mehta, Khyati Y, et al. "Metabolomic biomarkers of pancreatic cancer: a meta-analysis study." Oncotarget vol. 8,40 (2017): 68899-68915. doi: https://doi.org/10.18632/oncotarget.20324
Mehta KY, Wu HJ, Menon SS, Fallah Y, Zhong X, Rizk N, Unger K, Mapstone M, Fiandaca MS, Federoff HJ, Cheema AK. Metabolomic biomarkers of pancreatic cancer: a meta-analysis study. Oncotarget. 2017 Aug 18;8(40):68899-68915. doi: 10.18632/oncotarget.20324. eCollection 2017 Sep 15. PMID: 28978166; PMCID: PMC5620306.
Copy Download .nbib Format: NLM
Bioavailability, pharmacokinetics, and safety of riociguat given as an oral suspension or crushed tablet with and without food.

Pulmonary circulation

Saleh S, Frey R, Becker C, Unger S, Wensing G, Mück W.
PMID: 27162630
Pulm Circ. 2016 Mar;6:S66-74. doi: 10.1086/685020.

Riociguat is approved for the treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. Some patients have difficulty swallowing tablets; therefore, 2 randomized, nonblinded, crossover studies compared the relative bioavailability of riociguat oral suspensions and immediate-release (IR) tablet...

Cite
Saleh S, Frey R, Becker C, et al. Bioavailability, pharmacokinetics, and safety of riociguat given as an oral suspension or crushed tablet with and without food. Pulm Circ. 2016;6:S66-74doi: 10.1086/685020.
Saleh, S., Frey, R., Becker, C., Unger, S., Wensing, G., & Mück, W. (2016). Bioavailability, pharmacokinetics, and safety of riociguat given as an oral suspension or crushed tablet with and without food. Pulmonary circulation, 6S66-74. https://doi.org/10.1086/685020
Saleh, Soundos, et al. "Bioavailability, pharmacokinetics, and safety of riociguat given as an oral suspension or crushed tablet with and without food." Pulmonary circulation vol. 6 (2016): S66-74. doi: https://doi.org/10.1086/685020
Saleh S, Frey R, Becker C, Unger S, Wensing G, Mück W. Bioavailability, pharmacokinetics, and safety of riociguat given as an oral suspension or crushed tablet with and without food. Pulm Circ. 2016 Mar;6:S66-74. doi: 10.1086/685020. PMID: 27162630; PMCID: PMC4860539.
Copy Download .nbib Format: NLM
Lentic small water bodies: Variability of pesticide transport and transformation patterns.

The Science of the total environment

Ulrich U, Hörmann G, Unger M, Pfannerstill M, Steinmann F, Fohrer N.
PMID: 29128775
Sci Total Environ. 2018 Mar 15;618:26-38. doi: 10.1016/j.scitotenv.2017.11.032. Epub 2017 Nov 09.

Lentic small water bodies have a high ecological potential as they fulfill several ecosystem services such as the retention of water and pollutants. They serve as a hot spot of biodiversity. Due to their location in or adjacent to...

Cite
Ulrich U, Hörmann G, Unger M, et al. Lentic small water bodies: Variability of pesticide transport and transformation patterns. Sci Total Environ. 2017;618:26-38doi: 10.1016/j.scitotenv.2017.11.032.
Ulrich, U., Hörmann, G., Unger, M., Pfannerstill, M., Steinmann, F., & Fohrer, N. (2018). Lentic small water bodies: Variability of pesticide transport and transformation patterns. The Science of the total environment, 61826-38. https://doi.org/10.1016/j.scitotenv.2017.11.032
Ulrich, Uta, et al. "Lentic small water bodies: Variability of pesticide transport and transformation patterns." The Science of the total environment vol. 618 (2018): 26-38. doi: https://doi.org/10.1016/j.scitotenv.2017.11.032
Ulrich U, Hörmann G, Unger M, Pfannerstill M, Steinmann F, Fohrer N. Lentic small water bodies: Variability of pesticide transport and transformation patterns. Sci Total Environ. 2018 Mar 15;618:26-38. doi: 10.1016/j.scitotenv.2017.11.032. Epub 2017 Nov 09. PMID: 29128775.
Copy Download .nbib Format: NLM
Think You Can Shrink? A Proof-of-Concept Study for Men's Health Education Through Edutainment.

Journal of technology in behavioral science

Ungar T, Norman CD, Knaak S.
PMID: 29082309
J Technol Behav Sci. 2017;2(2):71-76. doi: 10.1007/s41347-016-0009-8. Epub 2017 Jan 11.

Connecting people to useful, actionable health resources is a substantive challenge that sits at the heart of health communication. Digital media provides means of producing, distributing and revising content and creates possibilities for new and multiple channels for reaching...

Cite
Ungar T, Norman CD, Knaak S. Think You Can Shrink? A Proof-of-Concept Study for Men's Health Education Through Edutainment. J Technol Behav Sci. 2017;2(2):71-76doi: 10.1007/s41347-016-0009-8.
Ungar, T., Norman, C. D., & Knaak, S. (2017). Think You Can Shrink? A Proof-of-Concept Study for Men's Health Education Through Edutainment. Journal of technology in behavioral science, 2(2), 71-76. https://doi.org/10.1007/s41347-016-0009-8
Ungar, Thomas, et al. "Think You Can Shrink? A Proof-of-Concept Study for Men's Health Education Through Edutainment." Journal of technology in behavioral science vol. 2,2 (2017): 71-76. doi: https://doi.org/10.1007/s41347-016-0009-8
Ungar T, Norman CD, Knaak S. Think You Can Shrink? A Proof-of-Concept Study for Men's Health Education Through Edutainment. J Technol Behav Sci. 2017;2(2):71-76. doi: 10.1007/s41347-016-0009-8. Epub 2017 Jan 11. PMID: 29082309; PMCID: PMC5640765.
Copy Download .nbib Format: NLM
Fitz -Hugh-Curtis syndrome in a male patient.

Journal of surgical case reports

Saurabh S, Unger E, Pavlides C.
PMID: 24960816
J Surg Case Rep. 2012 Mar 01;2012(3):12. doi: 10.1093/jscr/2012.3.12.

Fitz-Hugh-Curtis syndrome is a condition characterized by inflammation of the liver capsule with concomitant pelvic inflammation without involvement of liver parenchyma. It is classically seen in young women who present with sharp, pleuritic right upper quadrant pain, usually but...

Cite
Saurabh S, Unger E, Pavlides C. Fitz -Hugh-Curtis syndrome in a male patient. J Surg Case Rep. 2012;2012(3):12doi: 10.1093/jscr/2012.3.12.
Saurabh, S., Unger, E., & Pavlides, C. (2012). Fitz -Hugh-Curtis syndrome in a male patient. Journal of surgical case reports, 2012(3), 12. https://doi.org/10.1093/jscr/2012.3.12
Saurabh, S, et al. "Fitz -Hugh-Curtis syndrome in a male patient." Journal of surgical case reports vol. 2012,3 (2012): 12. doi: https://doi.org/10.1093/jscr/2012.3.12
Saurabh S, Unger E, Pavlides C. Fitz -Hugh-Curtis syndrome in a male patient. J Surg Case Rep. 2012 Mar 01;2012(3):12. doi: 10.1093/jscr/2012.3.12. PMID: 24960816; PMCID: PMC3649509.
Copy Download .nbib Format: NLM
Diastereo- and enantioselective synthesis of organometallic bis(helicene)s by a combination of C-H activation and dynamic isomerization.

Chemistry (Weinheim an der Bergstrasse, Germany)

Shen C, Anger E, Srebro M, Vanthuyne N, Toupet L, Roussel C, Autschbach J, Réau R, Crassous J.
PMID: 24173674
Chemistry. 2013 Dec 02;19(49):16722-8. doi: 10.1002/chem.201302479. Epub 2013 Oct 31.

Homochiral and heterochiral cis-bis-cycloplatinated-[6]helicene derivatives 1b(1,2), as representative examples of platina[6]helicenes that share a common platinum center, have been prepared. A diastereo- and enantioselective synthesis, which combines CH activation and dynamic isomerization from heterochiral structure 1b(2) into homochiral structure...

Cite
Shen C, Anger E, Srebro M, et al. Diastereo- and enantioselective synthesis of organometallic bis(helicene)s by a combination of C-H activation and dynamic isomerization. Chemistry. 2013;19(49):16722-8doi: 10.1002/chem.201302479.
Shen, C., Anger, E., Srebro, M., Vanthuyne, N., Toupet, L., Roussel, C., Autschbach, J., Réau, R., & Crassous, J. (2013). Diastereo- and enantioselective synthesis of organometallic bis(helicene)s by a combination of C-H activation and dynamic isomerization. Chemistry (Weinheim an der Bergstrasse, Germany), 19(49), 16722-8. https://doi.org/10.1002/chem.201302479
Shen, Chengshuo, et al. "Diastereo- and enantioselective synthesis of organometallic bis(helicene)s by a combination of C-H activation and dynamic isomerization." Chemistry (Weinheim an der Bergstrasse, Germany) vol. 19,49 (2013): 16722-8. doi: https://doi.org/10.1002/chem.201302479
Shen C, Anger E, Srebro M, Vanthuyne N, Toupet L, Roussel C, Autschbach J, Réau R, Crassous J. Diastereo- and enantioselective synthesis of organometallic bis(helicene)s by a combination of C-H activation and dynamic isomerization. Chemistry. 2013 Dec 02;19(49):16722-8. doi: 10.1002/chem.201302479. Epub 2013 Oct 31. PMID: 24173674.
Copy Download .nbib Format: NLM
Supplemental Cardioplegia Immediately before Graft Implantation may Improve Early Post-Transplantation Outcome.

Frontiers in surgery

Tevaearai Stahel HT, Unger D, Schmidli J, Gahl B, Englberger L, Kadner A, Eberle B, Mohacsi P, Carrel TP.
PMID: 25593970
Front Surg. 2014 Nov 28;1:46. doi: 10.3389/fsurg.2014.00046. eCollection 2014.

BACKGROUND: Preservation of cardiac grafts for transplantation is not standardized and most centers use a single administration of crystalloid solution at the time of harvesting. We investigated possible benefits of an additional dose of cardioplegia dispensed immediately before implantation.METHODS:...

Cite
Tevaearai Stahel HT, Unger D, Schmidli J, et al. Supplemental Cardioplegia Immediately before Graft Implantation may Improve Early Post-Transplantation Outcome. Front Surg. 2014;1:46doi: 10.3389/fsurg.2014.00046.
Tevaearai Stahel, H. T., Unger, D., Schmidli, J., Gahl, B., Englberger, L., Kadner, A., Eberle, B., Mohacsi, P., & Carrel, T. P. (2014). Supplemental Cardioplegia Immediately before Graft Implantation may Improve Early Post-Transplantation Outcome. Frontiers in surgery, 146. https://doi.org/10.3389/fsurg.2014.00046
Tevaearai Stahel, Hendrik T, et al. "Supplemental Cardioplegia Immediately before Graft Implantation may Improve Early Post-Transplantation Outcome." Frontiers in surgery vol. 1 (2014): 46. doi: https://doi.org/10.3389/fsurg.2014.00046
Tevaearai Stahel HT, Unger D, Schmidli J, Gahl B, Englberger L, Kadner A, Eberle B, Mohacsi P, Carrel TP. Supplemental Cardioplegia Immediately before Graft Implantation may Improve Early Post-Transplantation Outcome. Front Surg. 2014 Nov 28;1:46. doi: 10.3389/fsurg.2014.00046. eCollection 2014. PMID: 25593970; PMCID: PMC4286961.
Copy Download .nbib Format: NLM
Correction: The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer: Results from the EPIC Cohort.

PloS one

Roura E, Travier N, Waterboer T, de Sanjosé S, Bosch FX, Pawlita M, Pala V, Weiderpass E, Margall N, Dillner J, Gram IT, Tjønneland A, Munk C, Palli D, Khaw KT, Overvad K, Clavel-Chapelon F, Mesrine S, Fournier A, Fortner RT, Ose J, Steffen A, Trichopoulou A, Lagiou P, Orfanos P, Masala G, Tumino R, Sacerdote C, Polidoro S, Mattiello A, Lund E, Peeters PH, Bueno-de-Mesquita HB, Ramón Quirós J, Sánchez MJ, Navarro C, Barricarte A, Larrañaga N, Ekström J, Lindquist D, Idahl A, Travis RC, Merritt MA, Gunter MJ, Rinaldi S, Tommasino M, Franceschi S, Riboli E, Castellsagué X.
PMID: 26954296
PLoS One. 2016 Mar 08;11(3):e0151427. doi: 10.1371/journal.pone.0151427. eCollection 2016.

No abstract available.

Cite
Roura E, Travier N, Waterboer T, et al. Correction: The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer: Results from the EPIC Cohort. PLoS One. 2016;11(3):e0151427doi: 10.1371/journal.pone.0151427.
Roura, E., Travier, N., Waterboer, T., de Sanjosé, S., Bosch, F. X., Pawlita, M., Pala, V., Weiderpass, E., Margall, N., Dillner, J., Gram, I. T., Tjønneland, A., Munk, C., Palli, D., Khaw, K. T., Overvad, K., Clavel-Chapelon, F., Mesrine, S., Fournier, A., Fortner, R. T., Ose, J., Steffen, A., Trichopoulou, A., Lagiou, P., Orfanos, P., Masala, G., Tumino, R., Sacerdote, C., Polidoro, S., Mattiello, A., Lund, E., Peeters, P. H., Bueno-de-Mesquita, H. B., Ramón Quirós, J., Sánchez, M. J., Navarro, C., Barricarte, A., Larrañaga, N., Ekström, J., Lindquist, D., Idahl, A., Travis, R. C., Merritt, M. A., Gunter, M. J., Rinaldi, S., Tommasino, M., Franceschi, S., Riboli, E., & Castellsagué, X. (2016). Correction: The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer: Results from the EPIC Cohort. PloS one, 11(3), e0151427. https://doi.org/10.1371/journal.pone.0151427
Roura, Esther, et al. "Correction: The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer: Results from the EPIC Cohort." PloS one vol. 11,3 (2016): e0151427. doi: https://doi.org/10.1371/journal.pone.0151427
Roura E, Travier N, Waterboer T, de Sanjosé S, Bosch FX, Pawlita M, Pala V, Weiderpass E, Margall N, Dillner J, Gram IT, Tjønneland A, Munk C, Palli D, Khaw KT, Overvad K, Clavel-Chapelon F, Mesrine S, Fournier A, Fortner RT, Ose J, Steffen A, Trichopoulou A, Lagiou P, Orfanos P, Masala G, Tumino R, Sacerdote C, Polidoro S, Mattiello A, Lund E, Peeters PH, Bueno-de-Mesquita HB, Ramón Quirós J, Sánchez MJ, Navarro C, Barricarte A, Larrañaga N, Ekström J, Lindquist D, Idahl A, Travis RC, Merritt MA, Gunter MJ, Rinaldi S, Tommasino M, Franceschi S, Riboli E, Castellsagué X. Correction: The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer: Results from the EPIC Cohort. PLoS One. 2016 Mar 08;11(3):e0151427. doi: 10.1371/journal.pone.0151427. eCollection 2016. PMID: 26954296; PMCID: PMC4783099.
Copy Download .nbib Format: NLM
Discovery and Characterization of 2-Aminooxazolines as Highly Potent, Selective, and Orally Active TAAR1 Agonists.

ACS medicinal chemistry letters

Galley G, Beurier A, Décoret G, Goergler A, Hutter R, Mohr S, Pähler A, Schmid P, Türck D, Unger R, Zbinden KG, Hoener MC, Norcross RD.
PMID: 26985297
ACS Med Chem Lett. 2015 Dec 30;7(2):192-7. doi: 10.1021/acsmedchemlett.5b00449. eCollection 2016 Feb 11.

2-Aminooxazolines were discovered as a novel structural class of TAAR1 ligands. Starting from a known adrenergic compound 1, structural modifications were made to obtain highly potent and selective TAAR1 ligands such as 12 (RO5166017), 18 (RO5256390), 36 (RO5203648), and...

Cite
Galley G, Beurier A, Décoret G, et al. Discovery and Characterization of 2-Aminooxazolines as Highly Potent, Selective, and Orally Active TAAR1 Agonists. ACS Med Chem Lett. 2015;7(2):192-7doi: 10.1021/acsmedchemlett.5b00449.
Galley, G., Beurier, A., Décoret, G., Goergler, A., Hutter, R., Mohr, S., Pähler, A., Schmid, P., Türck, D., Unger, R., Zbinden, K. G., Hoener, M. C., & Norcross, R. D. (2016). Discovery and Characterization of 2-Aminooxazolines as Highly Potent, Selective, and Orally Active TAAR1 Agonists. ACS medicinal chemistry letters, 7(2), 192-7. https://doi.org/10.1021/acsmedchemlett.5b00449
Galley, Guido, et al. "Discovery and Characterization of 2-Aminooxazolines as Highly Potent, Selective, and Orally Active TAAR1 Agonists." ACS medicinal chemistry letters vol. 7,2 (2016): 192-7. doi: https://doi.org/10.1021/acsmedchemlett.5b00449
Galley G, Beurier A, Décoret G, Goergler A, Hutter R, Mohr S, Pähler A, Schmid P, Türck D, Unger R, Zbinden KG, Hoener MC, Norcross RD. Discovery and Characterization of 2-Aminooxazolines as Highly Potent, Selective, and Orally Active TAAR1 Agonists. ACS Med Chem Lett. 2015 Dec 30;7(2):192-7. doi: 10.1021/acsmedchemlett.5b00449. eCollection 2016 Feb 11. PMID: 26985297; PMCID: PMC4753552.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 752 entries